Skip to main content

QLGN

Stock
Health Care
Biotechnology

Performance overview

QLGN Price
Price Chart

Forward-looking statistics

Beta
0.80
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Company info

SectorHealth Care
IndustryBiotechnology
Employees4
Market cap$1.3M

Fundamentals

Enterprise value$3.6M
Revenue$0.0
Revenue per employee
Profit margin0.00%
Debt to equity0.54

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$17.27
Dividend per share
Revenue per share
Avg trading volume (30 day)$27K
Avg trading volume (10 day)$23K
Put-call ratio

Macro factor sensitivity

Growth-4.5
Credit+2.9
Liquidity+5.2
Inflation-2.2
Commodities-2.2
Interest Rates-3.9

Valuation

Dividend yield0.00%
PEG Ratio-3.16
Price to sales
P/E Ratio-3.16
Enterprise Value to Revenue
Price to book

Upcoming events

Next earnings dayAugust 15, 2023
Next dividend day
Ex. dividend day

News

Qualigen Surges 80% As QN-302 Shows Potential Preclinical Mechanism Of Action Against Prostate, Pancreatic Cancers

Qualigen Therapeutics Inc (NASDAQ: QLGN) shares are surging after highlighting posters at the American Association of Cancer Research (AACR). QN-302 showed potent anti-proliferative activity in a prostate cancer cell panel and anti-tumor activity in an in vivo metastatic.

Benzinga (April 12, 2022)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free